Cargando…
Reactivation of epigenetically silenced HER4/ERBB4 results in apoptosis of breast tumor cells
Experimental and clinical data support a growth inhibitory role for HER4 in breast cancer. Clinically HER4 expression is extinguished during breast tumorigenesis supporting a tumor suppressor function for HER4, however, a molecular mechanism to explain the selective loss of HER4 expression has remai...
Autores principales: | Das, P M, Thor, A D, Edgerton, S M, Barry, S K, Chen, D F, Jones, F E |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3007096/ https://www.ncbi.nlm.nih.gov/pubmed/20603612 http://dx.doi.org/10.1038/onc.2010.271 |
Ejemplares similares
-
Muc4\sialomucin Complex, A Specific Intramembrane Modulator of ERBB2/HER2/NEU, Potentiates Primary Tumor Growth and Suppresses Apoptosis in A Xenotransplanted Melanoma
por: Carraway, Coralie Carothers, et al.
Publicado: (2001) -
A New Monoclonal Antibody Demonstrates That Muc4, the Intramembrane Ligand for Erbb2/Her2/Neu, Is Overexpressed in Multiple Carcinomas
por: Zhang, Jin, et al.
Publicado: (2002) -
The ERα coactivator, HER4/4ICD, regulates progesterone receptor expression in normal and malignant breast epithelium
por: Rokicki, Jerzy, et al.
Publicado: (2010) -
A Review of HER4 (ErbB4) Kinase, Its Impact on Cancer, and Its Inhibitors
por: El-Gamal, Mohammed I., et al.
Publicado: (2021) -
Epigenetic silencing of TIMP4 in heart failure
por: Chaturvedi, Pankaj, et al.
Publicado: (2016)